Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Leukemia. 2019 Nov 18;34(4):1090–1101. doi: 10.1038/s41375-019-0632-4

Fig. 5.

Fig. 5

Overall survival of patients who showed decrease, increase, mixed pattern, or no change (stable) of eosinophil counts during follow-up. Data were censored for start cytoreductive therapy or corticosteroids. The p value refers to the comparison of all four survival curves as assessed by log rank test